FDA weighs a new kind of flu shot based on technology RFK Jr. has questioned

The FDA is poised to render a decision on Moderna's mRNA-based flu shot, which could be the first of its kind to market. The decision is expected to reverberate throughout the biotech industry.

The top 3

  1. First Inactivated Flu Vaccine Development: The first inactivated flu vaccine was developed in the 1930s by Thomas Francis Jr. and Jonas Salk with support from the U.S. Army, becoming licensed for civilian use in 1945.
  2. Live Attenuated Vaccine Introduction: The first intranasal, trivalent, cold-adapted live attenuated influenza vaccine (LAIV), FluMist, was approved for use in the United States in 2003.
  3. Recombinant Protein Vaccine Innovation: Recombinant protein flu vaccines, which use genetic engineering to produce hemagglutinin proteins without relying on chicken eggs, were first licensed by the FDA in 2013.

Sources

Open the full topic